Chronic mucocutaneous candidiasis due to gain-of-function mutation in STAT1.
Carey B, Lambourne J, Porter S, Hodgson T.
Oral Dis. 2019 Apr;25(3):684-692. doi: 10.1111/odi.12881. Epub 2018 Jun 8.
PMID:29702748
Primary immunodeficiency and chronic mucocutaneous candidiasis: pathophysiological, diagnostic, and therapeutic approaches.
Egri N, Esteve-Solé A, Deyà-Martínez À, Ortiz de Landazuri I, Vlagea A, García AP, Cardozo C, Garcia-Vidal C, Bartolomé CS, Español-Rego M, Yiyi L, Bosch-Amate X, Ferrando J, Yagüe J, Juan M, Alsina L.
Allergol Immunopathol (Madr). 2021 Jan 2;49(1):118-127. doi: 10.15586/aei.v49i1.20. eCollection 2021.
PMID:33528939
Chronic Mucocutaneous Candidiasis in Early Life: Insights Into Immune Mechanisms and Novel Targeted Therapies.
Shamriz O, Tal Y, Talmon A, Nahum A.
Front Immunol. 2020 Oct 16;11:593289. doi: 10.3389/fimmu.2020.593289. eCollection 2020.
PMID:33178226
Chronic mucocutaneous candidiasis.
Kirkpatrick CH.
Pediatr Infect Dis J. 2001 Feb;20(2):197-206. doi: 10.1097/00006454-200102000-00017.
PMID:11224843
Chronic mucocutaneous candidiasis.
Dwyer JM.
Annu Rev Med. 1981;32:491-7. doi: 10.1146/annurev.me.32.020181.002423.